EEF1A2 and cancer: Taken together, these data demonstrate that AM52.1 exhibits higher specificity for the cancer-associated STn antigen compared to the currently available anti-STn antibodies, while AM51.1, despite being isolated from the same screening, displays cross-reactivity with other sialylated structures and appears to rely on a specific STn presentation context.